Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 21 Jun 2023 – 20 Aug 2026, limited by quant BFSI Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | quant BFSI Fund | Nifty 500 |
|---|---|---|
| 21 Jun 2023 | ₹100.00 | ₹100.00 |
| 25 Sep 2023 | ₹117.86 | ₹106.35 |
| 31 Dec 2023 | ₹137.61 | ₹119.63 |
| 05 Apr 2024 | ₹158.71 | ₹127.55 |
| 10 Jul 2024 | ₹170.43 | ₹141.48 |
| 15 Oct 2024 | ₹167.93 | ₹146.15 |
| 19 Jan 2025 | ₹152.42 | ₹133.49 |
| 25 Apr 2025 | ₹152.14 | ₹134.53 |
| 31 Jul 2025 | ₹176.17 | ₹141.09 |
| 04 Nov 2025 | ₹184.01 | ₹145.78 |
| 08 Feb 2026 | ₹189.49 | ₹144.29 |
| 16 May 2026 | ₹188.13 | ₹138.73 |
| 20 Aug 2026 | ₹203.24 | ₹144.78 |
| Metric | quant · Regular NAV ₹20.35 Very High risk ★★★★☆ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +15.20% | +5.83% | |
| +21.87% | +15.63% | |
| — | +13.23% | |
| — | +13.85% | |
| +25.12% | +12.26% | |
| +16.67% | — | |
| +23.51% | +15.60% | |
| — | +14.52% | |
| — | +13.74% | |
| Risk | ||
| 19.07% | 15.62% | |
| 0.81 | 0.43 | |
| 1.11 | 0.59 | |
| -22.88% | -23.65% | |
| Nifty 500 | — | |
| +8.06% | +3.42% | |
| 1.06 | 0.95 | |
| 122.5% | 105.9% | |
| 85.2% | 93.6% | |
| 3.46% | 2.39% | |
| ₹767.76Cr | ₹1,161Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| — | 45% | |
| Sanjeev Sharma | — | |
| 21 Jun 2023 | — | |
| 11 | — | |
| 70.1% | — | |
| 10.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.